{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Miranda-Ortiz H"],"funding":["Consejo Nacional de Ciencia y Tecnología"],"pagination":["e0255807"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8372963"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["16(8)"],"pubmed_abstract":["The use of saliva for the diagnosis of SARS-CoV-2 has shown to be a good alternative to nasopharyngeal swabs (NPS), since it permits self-collection, avoids the exposure of healthy persons to infected patients, reduces waiting times, eliminates the need of personal protective equipment and is non-invasive. Yet current saliva testing is still expensive due to the need of specialized tubes containing buffers to stabilize the RNA of SARS-CoV-2 and inactivate the virus. These tubes are expensive and not always accessible in sufficient quantities. We now developed an alternative saliva testing method, using TRIzol for extraction, viral inactivation, and storage of SARS-CoV-2 RNA, combined with RT-qPCR, which was comparable in its performance to NPS. Paired saliva samples and NPS were taken from"],"journal":["PloS one"],"pubmed_title":["Development of an alternative saliva test for diagnosis of SARS-CoV-2 using TRIzol: Adapting to countries with lower incomes looking for a large-scale detection program."],"pmcid":["PMC8372963"],"funding_grant_id":["312224"],"pubmed_authors":["Lopez-Vergara Anaya T","Ruiz-Garcia EB","Becker I","Lopez-Flores A la Torre A","Valdes-Reyes M","Astudillo-de la Vega H","Nava-Monroy R","Vilar-Compte D","Sanchez-Montes S","Munoz-Rivas A","Mendez-Perez A","Fernandez-Figueroa EA","Coquis-Navarrete U","Miranda-Ortiz H","Gabino-Lopez B","Mendez-Galvan J"],"additional_accession":[]},"is_claimable":false,"name":"Development of an alternative saliva test for diagnosis of SARS-CoV-2 using TRIzol: Adapting to countries with lower incomes looking for a large-scale detection program.","description":"The use of saliva for the diagnosis of SARS-CoV-2 has shown to be a good alternative to nasopharyngeal swabs (NPS), since it permits self-collection, avoids the exposure of healthy persons to infected patients, reduces waiting times, eliminates the need of personal protective equipment and is non-invasive. Yet current saliva testing is still expensive due to the need of specialized tubes containing buffers to stabilize the RNA of SARS-CoV-2 and inactivate the virus. These tubes are expensive and not always accessible in sufficient quantities. We now developed an alternative saliva testing method, using TRIzol for extraction, viral inactivation, and storage of SARS-CoV-2 RNA, combined with RT-qPCR, which was comparable in its performance to NPS. Paired saliva samples and NPS were taken from","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021","modification":"2025-08-13T03:04:11.492Z","creation":"2025-08-13T03:04:11.492Z"},"accession":"S-EPMC8372963","cross_references":{"pubmed":["34407100"],"doi":["10.1371/journal.pone.0255807"]}}